Latest news with #Lange
Yahoo
3 days ago
- Business
- Yahoo
EU seeks lasting agreement with the US, negotiator says
The European Union is insisting that any agreement reached in the trade dispute with the US government must be permanent. "If we reach an agreement, it cannot be the case that new tariffs are imposed just a few days later," Bernd Lange, chair of the European Parliament's Trade Committee, told Deutschlandfunk German public radio. If a stable solution cannot be found, the EU is prepared to impose counter-tariffs, Lange asserted. "We will not allow ourselves to be pressured or blackmailed," the EU negotiator added. Lange is currently in Washington for talks with the US government. The two sides have until July 9 to reach an agreement. If they fail to do so, US President Donald Trump wants to impose high tariffs on EU imports. Although the federal Court of International Trade had declared almost all of the tariffs imposed by Trump under an emergency law to be illegal, a US appeals court recently temporarily overturned the decision. According to Lange, this is a transitional arrangement until the matter is finally clarified. He stressed that customs policy is a matter for the US Congress and should not be subject to the whims of the US president. The EU continues to seek an agreement and has offered higher imports of liquefied natural gas and semiconductors, he pointed out. On the question of possible concessions on the part of Europe, Lange said that the removal of certain tariffs and the mutual recognition of standards could be discussed. However, European legislation – for example on food, chemicals or in the digital sector – was not negotiable. He cited the ban on hormone-treated beef as an example.
Axios
3 days ago
- Business
- Axios
The global economy's trade paralysis
At any moment, a Truth Social post — and now a court ruling — can upend the global trade system. Why it matters: The world economy has never seen anything like this. The tariff legal fight injects new uncertainty into what was already a historically unpredictable situation. Businesses are in limbo about what it will cost to bring goods into the country. Foreign officials see new leverage in trade talks that could drag out even longer. The billions in tariff revenue expected to help offset the cost of Trump's tax bill could all but vanish. What they're saying: "One day it makes sense to ship and the next day it doesn't," a port official tells Axios. The big picture: Economists expected front-loading on steroids — businesses would take advantage of a tariff halt and rush to import goods, which could push off the risk of shortages and consumer price hikes. Never mind all that now. Driving the news: The Court of International Trade issued a late-night ruling on Wednesday that blocked many of Trump's sweeping tariffs. Another shocker came less than 24 hours later. The U.S. Court of Appeals for the Federal Circuit ruled the import levies could remain, as it reviews arguments from both sides. "As the courts now play a larger role in the outcome of Trump's tariffs, trade policy uncertainty will only become more entrenched, stifling business investment and consumer spending on durable goods," Bernard Yaros, an economist at Oxford Economics, wrote in a note. The intrigue: Europe's trade delegation was in Washington this week, just as it became clear courts could kill many of the tariffs that brought them to the negotiating table in the first place. "It makes no sense to negotiate about that," Bernd Lange, a key European Parliament lawmaker leading the trade delegation, told Axios, referring to the "Liberation Day" tariffs that might ultimately be illegal. "I guess now we have a better position for negotiation," Lange said just minutes before the appeals court issued its stay — a sign of how quickly dynamics can change. Lange admitted that he has started waking up a half-hour earlier since Trump was inaugurated "to follow the news coming from the United States." He is on Truth Social. The other side: The economic threat of steep tariffs still lingers. The Trump administration could still impose tariffs under the same authorities officials previously used on to impose levies on steel, aluminum and autos. Those powers require more processes to activate, though Commerce Secretary Howard Lutnick has said he is moving in "Trump time" to carry them out. While the Court of International Trade said Trump did not have unlimited tariff powers, the ruling was more ambiguous about whether he could impost some tariffs, Ilya Somin, one of the lawyers who represented small businesses in the case, said. The bottom line: Economic uncertainty was already at peak levels.
Yahoo
6 days ago
- Business
- Yahoo
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 13 / 2025 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 27, 2025 – Zealand Pharma A/S ("the Company" or 'Zealand Pharma') (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand Pharma's shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons and hereby publishes the information on such transactions. Please see the attached file(s). # # # About Zealand Pharma A/SZealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the United States. For more information about Zealand's business and activities, please visit ContactsAdam Lange (Investors)Vice President, Investor Relations Zealand PharmaEmail: alange@ Neshat Ahmadi (Investors)Investor Relations ManagerZealand PharmaEmail: neahmadi@ Anna Krassowska, PhD (Investors and Media) Vice President, Investor Relations & Corporate Communications Zealand Pharma Email: akrassowska@ Attachment 27.05.2025 - PDMR notification Adam Steensberg
Yahoo
09-05-2025
- Business
- Yahoo
Cheboygan Commons update on May 13 to focus on project's environmental challenges
CHEBOYGAN — An update on Cheboygan Commons, a redevelopment project designed to replace the closed paper mill along the Cheboygan River, will occur at 6 p.m. on May 13 at the Cheboygan Area Public Library. Sharen Lange, project coordinator for Cheboygan Commons, will discuss the current hold on the project, site remediation and what steps will be taken to get it moving forward. She also wants to focus on the project's environmental challenges as part of Earth Week Plus, which spotlights conservation and protecting the earth's resources. "This is not so much about what is in the project as we have already shared with the community what we want to do with that site. I believe it is important to share images that show environmental concerns and some of the discoveries that have happened while working with EGLE (Michigan Department of Environment, Great Lakes, and Energy)," said Lange. More: Large crowd hears about Cheboygan Commons project to replace closed paper mill In 2023, a fire destroyed a warehouse across the street from the Tissue Depot paper mill. Although the building housing the paper operations wasn't damaged, the mill never resumed operations after the blaze. Developer Bob Pulte has proposed transitioning the 14-acre site into a mixed-use development featuring housing, a riverfront restaurant, a boutique style hotel, commercial space for retail or offices, a fitness center and a small special events center. Subscribe Check out our latest offers and read the local news that matters to you Currently, there is no work going on at the site. "The project's current status is due to the lawsuit over the hydroelectric power plant and the seller not being able to deliver a clear title," Lange said. Recently, Cheboygan Commons and the city of Cheboygan were dismissed from the lawsuit. Lange is hopeful everything can be cleared up this year. "We are not saying (the project) is dead but we don't have a clear pathway to obtain the property and get to work," Lange added. The price tag for Cheboygan Commons has doubled to $100 million from the original $50 million estimate. Lange said Pulte and project partners now have a better idea of what will be required to complete the project. The rising price has not deterred Pulte, according to Lange. "Bob Pulte still believes in Cheboygan and still believes in this project," she said. — Contact Paul Welitzkin at pwelitzkin@ This article originally appeared on Cheboygan Daily Tribune: Cheboygan Commons update at library on May 13 to focus on environmental challenges at former paper mill site
Yahoo
06-05-2025
- Business
- Yahoo
As Rite Aid locations begin to close, local pharmacies across the country struggle
(WHTM) — The economic troubles at Rite Aid have been well-documented, as locations here and nationwide are closing. Many local independent pharmacies are struggling, as well. Another day, another pharmacy closing. It is happening nationwide, and leaving communities with fewer and fewer local pharmacies. Are there any solutions? It's a tough time at the Newport Drug Center, as employees say goodbye to longtime customers. This 100-year-old store posted on Facebook that it is the latest pharmacy to close. 'Everybody's sad,' said co-owner Randy Lange. 'All the customers are telling us how they are going to miss us, how they love it here.' Lange says he's been squeezed out by insurance companies and benefits managers. 'We are out of control of our own pricing,' said Lange. 'They can lower it down to whatever they want, and in the last year, they lowered it down below the actual cost.' It's a national trend: thousands of pharmacies across the country say it's become too tough to make a profit, and they have been forced to close their doors. Kris Krese of the National Association of chain drug stores says benefit managers, middlemen essentially, are supposed to lower costs for consumers, but he says the fees they charge pharmacies have skyrocketed. 'When you look at the PBMs, they're profits, or I should say their revenues, have doubled for the past two decades,' said Krese. A proposed bill in Congress, sponsored by both Democrats and Republicans, would regulate PBMs and help small drug stores. But here, help would be too late, frustrating longtime customers like Bev Holiday.'They mean so much to us, and it was a sad note yesterday when we heard that.'What you can do is support your local pharmacy, if you still have one, which could help them stay in business. That way, you don't waste your money. Find more stories on Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
